Economic impact

Clinical trials conducted in 2015 are estimated to result in profits from future medicine sales sufficient to generate a 4.2% rate of return, in net present values. That is, future return will be 104.2% of current total trial costs (including successful and unsuccessful trials). Clinical trials conducted in Thailand in 2015 are expected to resultin net economic return of medicines produced of ฿436 million (USD 13.4 million).